U.S. market Closed. Opens in 11 hours 26 minutes

PXMD | PaxMedica, Inc. Common Stock Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/A
Operating Expenses16.15M10.60M7.20M5.57M598.61K
Selling, General & Admin12.23M8.82M4.97M4.63M114.50K
Research & Development3.91M1.79M2.22M936.78K484.11K
Other Operating ExpensesN/A-5.51M173.35K-53.54KN/A
Operating Income-16.15M-10.60M-7.20M-5.57M-598.61K
Other Expenses / Income-2.14M-4.20M-3.03M-2.26MN/A
Before Tax Income-18.29M-14.80M-10.23M-7.83M-598.61K
Income Tax Expenses-167.90K4.19M2.81M663.00K-171.86K
Net Income-18.29M-18.99M-13.03M-8.49M-598.61K
Interest Expenses9.16K5.24K2.81M609.46KN/A
Basic Shares Outstanding1.66M707.98K692.91K692.91K10.02M
Diluted Shares Outstanding1.66M707.98K692.91K692.91K10.02M
EBITDA-16.15M-16.51M-7.02M-5.62M-598.61K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-18.45M-14.80M-7.42M-7.22M-770.47K
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙